Cardiovascular Systems names Scott R. Ward permanent CEO
Mr. Ward became a member of CSI's Board of Directors in 2013 and was named Chairman of CSI's Board of Directors in November, 2014. Since 2013, he has been a Managing Director at SightLine Partners, and, since 2011, he has been President of Raymond Holdings.
From 1981 to 2010, Mr. Ward was employed by Medtronic, Inc. and held a number of senior leadership positions. He was Senior Vice President and President of Medtronic's CardioVascular business from May 2007 to November 2010.
Prior to that Mr. Ward was Senior Vice President and President of Medtronic's Vascular business from May 2004 to May 2007, Senior Vice President and President of Medtronic's Neurological and Diabetes Business, from February 2002 to May 2004, and was President of Medtronic's Neurological business from January 2000 to January 2002.
Mr. Ward was Vice President and General Manager of Medtronic's Drug Delivery Business from 1995 to 2000.
Prior to that, he led Medtronic's Neurological Ventures in the successful development of new therapies.
Mr. Ward is Chairman of the Board of Creganna-Tactx Medical and serves on the Board of ImpediMed. He became Interim President and Chief Executive Officer of CSI on December 1, 2015. ■
LATEST MOVES FROM Minnesota
- ECMC Group appoints Jeremy J. Wheaton as CEO
- Lunds & Byerlys appoints Pam Osborn as CFO
- Allete adds Robert P. Powers to board
- Target appoints Minsok Pak as executive vice president
- Polaris Industries appoints George W. Bilicic to board
More inside POST
China invests $9.1 billion in Rosneft Companies